Stephanie Woodall

Stephanie Woodall

Company: KSQ Therapeautics

Job title: Director of Quality


Workshop A – Developing an Analytical Genotoxicity Package: From Preclinical Development Through Drug Product Release & Beyond 9:00 am

A new generation of gene modified TIL therapy is on the horizon for patients, with genome editing approaches now being commonly employed as means to enhance TIL activity and persistence in the hostile microenvironment of solid tumors. Since genome editing may increase genotoxicity risk, and due to the importance of complying with an evolving regulatory…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.